CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin for Phase 2 Clinical Trial Oct 20, 2020 8:00am EDT
CNS Pharmaceuticals Highlights New Balancing Act Segment on Glioblastoma Airing on Lifetime TV Oct 12, 2020 8:00am EDT
CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin Sep 24, 2020 8:00am EDT
CNS Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Sep 17, 2020 8:00am EDT
CNS Pharmaceuticals to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference Sep 11, 2020 8:00am EDT
CNS Pharmaceuticals Announces Appointment of Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute, to Science Advisory Board Aug 27, 2020 8:00am EDT
